Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAllergy/Clinical ImmunologyRegence Allergy Test Policy Update | OpenPayer
    Ask Trek AI about this page
    CurrentRegence BlueCross BlueShieldPolicy N/A

    Allergy and Sensitivity Tests of Uncertain Efficacy

    Customize your policy alerts

    Sign up for all regence policy alerts

    Know when regence releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of allergy and sensitivity tests considered investigational because scientific evidence does not permit conclusions regarding their effects on health outcomes. It addresses tests of uncertain efficacy or primarily used in research settings and does not address allergy tests considered clinically useful.

    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyAllergy and Sensitivity Tests of Uncertain Efficacy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateJune 1, 2027
    Key ActionInform members before rendering investigational services that they are likely to be financially responsible for the cost.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    15Investigational allergy and sensitivity tests
    InvestigationalCoverage stance

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ResearchPrimary setting for certain tests
    11Listed procedure codes

    Investigational Allergy and Sensitivity Tests

    Investigational allergy and sensitivity tests

    Each of the following allergy and sensitivity tests is considered investigational because scientific evidence does not permit conclusions regarding their effects on health outcomes.

    Listed investigational allergy or sensitivity test

    • ALCAT automated food test: Antigen leukocyte cellular antibody (ALCAT) automated food test.
    • Applied kinesiology allergy test.
    • Conjunctival challenge test (ophthalmic mucous membrane test).
    • Cytotoxic food tests.
    • Electrodermal testing, also known as electro-acupuncture.
    • Hair analysis.
    • IgA food panel tests.
    • IgG/IgG4 allergen-specific antibody and food tests: IgG/IgG4 allergen-specific antibody test and food tests.
    • Iridology.
    • LEAP-MRT: Lifestyle Eating and Performing-Mediator Release Test (LEAP-MRT).
    • Leukocyte histamine release test (LHRT).
    • Nasal challenge test.
    • Passive transfer or P-X test: Passive transfer or P-X (Prausnitz-Küstner) test; now considered obsolete and replaced by radioallergosorbent tests.
    • Provocation-neutralization test: Provocation-neutralization food or food additive allergy test.
    • Rebuck skin window test; no longer in use.

    Investigational allergy and sensitivity tests

    The following allergy tests are considered investigational because research is insufficient and evidence-based clinical practice guidelines do not recommend them.

    Investigational allergy test

    • ALCAT test: Antigen leukocyte cellular antibody (ALCAT) test.
    • Applied kinesiology.
    • Cytotoxic tests.
    • Electrodermal testing.
    • Hair analysis.

    Clinically useful allergy tests, including tests recognized by the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) for diagnosis and management, are outside the scope of this policy. This policy addresses only allergy tests of uncertain efficacy or tests used primarily in research settings.

    Codes

    CodesCPT
    0598UGastroenterology (irritable bowel syndrome), IgG antibodies to 18 food items by enzyme-linked immunosorbent assay (ELISA), whole blood or serum, report as elevated (positive) or normal (negative) antibody levels.
    83516Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method.
    86001Allergen specific IgG quantitative or semiquantitative; each allergen.
    86003Allergen specific IgE; quantitative or semiquantitative, crude allergen extract, each.
    86005Allergen specific IgE; qualitative, multiallergen screen (eg, disk, sponge, card); allergen specific IgE; quantitative or semiquantitative, recombinant or purified.
    86008Allergen specific IgE; quantitative or semiquantitative, recombinant or purified component, each.
    86343Leukocyte Histamine Release Test (LHR).
    86486Skin test; unlisted antigen, each.
    95060Ophthalmic mucous membrane tests.
    95065Direct nasal mucous membrane test.
    1–10 of 11
    1/2

    Coverage and Claims Guidance

    Denial Risk

    Investigational Test Denial Condition

    The following allergy and sensitivity tests are considered investigational because scientific evidence does not permit conclusions regarding their effects on health outcomes.

    Billing Rule

    Contract Exclusion for Investigational Services

    Applicable contracts exclude services or procedures considered investigational or cosmetic, subject to the contract terms. Providers may bill members for these services and should inform members before rendering them that they are likely to be financially responsible.

    Clinical Background

    Allergy is an acquired potential for adverse reactions mediated by the immune system, commonly involving immunoglobulin E antibodies. Allergens may include pollens, mold spores, animal danders, dust, foods, insect venoms, latex, and drugs. Evaluation generally includes a careful history and physical examination and may use clinically useful allergy tests to confirm the cause of a reaction. Once the causative agent is identified, management may include avoidance, medication, or immunotherapy.

    This policy addresses allergy tests whose efficacy is uncertain or that are used primarily in research settings. Tests considered useful in the clinical setting are not addressed by this policy.

    Key Terms

    Allergy
    DefinitionAn acquired potential for developing adverse reactions mediated by the immune system, commonly via immunoglobulin E (IgE) antibodies.
    Clinical manifestationAllergic disease represents the clinical manifestations of these adverse immune responses.
    Management optionsOnce the allergy-causing agent is identified, treatment may include avoidance, medication, or immunotherapy.
    Allergen
    DefinitionAny substance that can cause an allergic reaction.
    Common examplesAllergens may include pollens, mold spores, animal danders, dust, foods, insect venoms, latex, and drugs.
    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyAllergy and Sensitivity Tests of Uncertain Efficacy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewAug 1, 2026
    Next Review DateJune 1, 2027
    Key ActionInform members before rendering investigational services that they are likely to be financially responsible for the cost.
    SourceLink
    On This Page
    Investigational Allergy and Sensitivity TestsCodesCoverage and Claims GuidanceClinical BackgroundKey Terms
    IgA food panel tests.
  1. IgG and IgG4 testing: IgG and IgG4 allergen-specific antibody or food test.
  2. Iridology.
  3. LEAP-MR.
  4. Passive transfer or P-X test.
  5. Provocation-neutralization.
  6. Rebuck skin window test.
  7. Leukocyte histamine release test: Leukocyte Histamine Release Test (LHRT).
  8. Conjunctival challenge tests: Conjunctival Challenge Tests.
  9. Nasal challenge tests: Nasal Challenge Tests.
  10. Denial Risk

    Investigational Allergy Tests: Claims Implications

    Claims for the following allergy and sensitivity tests should be treated as investigational and are subject to denial under applicable contract terms. These tests lack sufficient evidence of effectiveness and are not recommended by evidence-based clinical practice guidelines.

    • Antigen leukocyte cellular antibody (ALCAT) automated food test
    • Applied kinesiology allergy test
    • Conjunctival challenge test (ophthalmic mucous membrane test)
    • Cytotoxic food tests
    • Electrodermal testing (also known as electro-acupuncture)
    • Hair analysis
    • IgA food panel tests
    • IgG/IgG4 allergen-specific antibody and food tests
    • Iridology
    • Lifestyle Eating and Performing-Mediator Release Test (LEAP-MRT)
    • Leukocyte histamine release test (LHRT)
    • Nasal challenge test
    • Passive transfer or P-X (Prausnitz-Küstner) test
    • Provocation-neutralization food or food additive allergy test
    • Rebuck skin window test
    Typical characteristics
    Allergens are often common, usually harmless substances.
    Allergy test of uncertain efficacy
    DefinitionAn allergy test addressed by this policy because its efficacy is uncertain or it is used primarily in research settings.
    Policy scopeThis policy addresses only allergy tests of uncertain efficacy and those used primarily in research settings.
    Excluded from scopeTests that may be considered useful in the clinical setting are not addressed by this policy.